Cardiac pacing has evolved considerably over the years from its initial introduction as a lifesaving measure by asynchronous ventricular pacing. Pitfalls of ventricular-only pacing were recognized relatively early, which led to the introduction of atrioventricular (AV) synchronous pacing that was subjected to rigorous clinical studies. Cardiovascular implantable electronic device (CIED) is a term that encompasses pacemakers for arrhythmia treatment, implantable cardioverter defibrillators (ICDs) for arrhythmia management, and cardiac resynchronization therapy (CRT) devices for systolic dysfunction with conduction delays. Cardiac arrhythmias have an estimated prevalence of 14.4 million patients in the United States, and they account for approximately 40,700 deaths annually.1 As the indications for device placement continue to expand and with data supportive of device placement compared to medical therapy well established, CIEDs are becoming common in our patient population.Approximately one million patients worldwide receive a pacemaker or implantable cardioverter defibrillator (ICD) each year.
What You Will Learn
• Who are the key suppliers/CMOs of pacing/resynchronization devices?
• What medical device sourcing services are offered by companies in the pacing/resynchronization space?
• What is the distribution of contract medical device suppliers by device class?
• Which countries/regions dominate the pacing/resynchronization market?
• How do I find a list of companies that can perform the tasks that I seek for the devices I require?
Summary of Contents
Pacemaker Market Overview
Geographic Global Dispersion of Pacemaker Suppliers, excluding USA
Geographic Dispersion of Pacemaker Suppliers in the US
Pacemaker Product Activity by Product Code and Supplier
Products by Device Class and Supplier
Services – Listed by Suppliers and Product Code
Pacemaker Suppliers – Company Directory